[A therapeutic protocol with cefoperazone in bronchopneumopathy in mucoviscidosis].
Cystic fibrosis, a hereditary chronically evolving disease, is characterized by special predisposition to bronchial infections, especially by Pseudomonas strains. In the present open noncomparative study, the therapeutic efficacy of cefoperazone in respiratory infections by Pseudomonas aeruginosa in 25 children suffering from cystic fibrosis has been evaluated. Results were favorable, since both the specific symptoms of the infection and the general condition of the patients was markedly improved although the eradication of Pseudomonas was not achieved.
Manca
A
A
Istituto Policattedra di Pediatria Clinica e Sociale, Università degli Studi di Bari.
Giannuzzi
R
R
Mazzei
S
S
Nardelli
F
F
Rigillo
N
N
D000293:Adolescent; D001996:Bronchopneumonia / Q000188:drug therapy* / Q000209:etiology; D002438:Cefoperazone / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003550:Cystic Fibrosis / Q000150:complications* / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology
D002438:Cefoperazone
Studio di un protocollo terapeutico con cefoperazone nella broncopneumopatia mucoviscidosa.